Your browser doesn't support javascript.
loading
Comparison of the validity, perceived usefulness and usability of I-MeDeSA and TEMAS, two tools to evaluate alert system usability: a study protocol.
Marcilly, Romaric; Zheng, Wu Yi; Beuscart, Regis; Baysari, Melissa T.
Afiliación
  • Marcilly R; Univ. Lille, CHU Lille, ULR 2694 - METRICS: Évaluation des technologies de santé et des pratiques médicales, F-59000 Lille, France romaric.marcilly@univ-lille.fr.
  • Zheng WY; Inserm, CIC-IT 1403, F-59000 Lille, France.
  • Beuscart R; Black Dog Institute, Randwick, New South Wales, Australia.
  • Baysari MT; Univ. Lille, CHU Lille, ULR 2694 - METRICS: Évaluation des technologies de santé et des pratiques médicales, F-59000 Lille, France.
BMJ Open ; 11(8): e050448, 2021 08 05.
Article en En | MEDLINE | ID: mdl-34353806
INTRODUCTION: Research has shown that improvements to the usability of medication alert systems are needed. For designers and decisions-makers to assess usability of their alert systems, two paper-based tools are currently available: the instrument for evaluating human-factors principles in medication-related decision support alerts (I-MeDeSA) and the tool for evaluating medication alerting systems (TEMAS). This study aims to compare the validity, usability and usefulness of both tools to identify their strengths and limitations and assist designers and decision-makers in making an informed decision about which tool is most suitable for assessing their current or prospective system. METHODS AND ANALYSIS: First, TEMAS and I-MeDeSA will be translated into French. This translation will be validated by three experts in human factors. Then, in 12 French hospitals with a medication alert system in place, staff with expertise in the system will evaluate their alert system using the two tools successively. After the use of each tool, participants will be asked to fill in the System Usability Scale (SUS) and complete a survey on the understandability and perceived usefulness of each tool. Following the completion of both assessments, participants will be asked to nominate their preferred tool and relay their opinions on the tools. The design philosophy of TEMAS and I-MeDeSA differs on the calculation of a score, impacting the way the comparison between the tools can be performed. Convergent validity will be evaluated by matching the items of the two tools with respect to the usability dimensions they assess. SUS scores and answers to the survey will be statistically compared for I-MeDeSA and TEMAS to identify differences. Free-text responses in surveys will be analysed using an inductive approach. ETHICS AND DISSEMINATION: Ethical approval is not required in France for a study of this nature. The results will be published in a peer-reviewed journal.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sistemas de Apoyo a Decisiones Clínicas / Sistemas de Entrada de Órdenes Médicas Tipo de estudio: Observational_studies / Prognostic_studies Aspecto: Ethics Límite: Humans País/Región como asunto: Europa Idioma: En Revista: BMJ Open Año: 2021 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sistemas de Apoyo a Decisiones Clínicas / Sistemas de Entrada de Órdenes Médicas Tipo de estudio: Observational_studies / Prognostic_studies Aspecto: Ethics Límite: Humans País/Región como asunto: Europa Idioma: En Revista: BMJ Open Año: 2021 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Reino Unido